减重手术后出院后肝素预防与静脉血栓栓塞及出血风险
本研究基于Truven Health MarketScan数据库(2007-2015)的回顾性队列,纳入43,493例成人减重手术患者,仅6%接受出院后肝素预防。倾向评分调整后,出院后肝素预防与静脉血栓栓塞风险降低无显著关联(OR 0.77,95%CI 0.41-1.46),但与出血风险显著升高相关(OR 1.47,95%CI 1.14-1.88)。
要点
- 减重手术后出院后肝素预防使用率低,仅6%。
- 调整后出院后肝素预防未显著降低90天VTE风险。
- 出院后肝素预防与出血风险显著增加相关。
核心结论
- 减重手术后出院后肝素预防不常见,且未与较低的VTE风险相关,而与较高的出血风险相关。
研究设计与样本
- 回顾性队列研究,使用Truven Health MarketScan数据库(2007-2015),纳入43,493例接受袖状胃切除术或胃旁路术的成人患者,采用倾向评分调整回归模型。
主要发现
- 在43,493例患者中,6%接受了出院后肝素预防。
- 总体224例(0.52%)发生VTE,806例(1.85%)发生出血。
- 未调整VTE率在出院后肝素预防组与非预防组间无差异(0.39% vs. 0.52%,p=0.347)。
- 未调整出血率出院后肝素预防组更高(2.74% vs. 1.80%,p<0.001)。
- 调整后,出院后肝素预防组VTE风险降低23%无统计学意义(OR 0.77,95%CI 0.41-1.46),出血风险升高47%有统计学意义(OR 1.47,95%CI 1.14-1.88)。
临床怎么用
- 减重手术后常规使用出院后肝素预防需权衡VTE获益与出血风险,当前证据不支持其显著降低VTE。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Venous thromboembolism (VTE) is a significant cause of morbidity and mortality after bariatric surgery. Roughly 80% of VTEs occur post-discharge. The frequency of post-discharge heparin (PDH) prophylaxis use is unknown, and evidence about benefits and risks is limited. We aimed to determine the rate of use of PDH prophylaxis and evaluate its relationship with VTE and bleeding events. METHODS: Using the Truven Health MarketScan® database, we performed a retrospective cohort study (2007-2015) of adult patients who underwent sleeve gastrectomy or gastric bypass. We determined PDH prophylaxis from outpatient pharmacy claims, and post-discharge 90-day VTE and bleeding events from outpatient and inpatient claims. We used propensity score-adjusted regression models to mitigate confounding bias. RESULTS: Among 43,493 patients (median age 45 years; 78% women; 77% laparoscopic gastric bypass, 17% laparoscopic sleeve gastrectomy, 6% open gastric bypass), 6% received PDH prophylaxis. Overall, 224 patients (0.52%) experienced VTEs, and 806 patients (1.85%) experienced bleeding. The unadjusted VTE rate did not differ between patients who did and did not receive PDH prophylaxis (0.39% vs. 0.52%, respectively; p = 0.347). The unadjusted bleeding rate was higher for the PDH prophylaxis group (2.74% vs. 1.80%, p < 0.001). In our adjusted analysis, a 23% lower risk of VTE in the PDH prophylaxis group was not statistically significant (odds ratio [OR] 0.77, 95% confidence interval [CI] 0.41 to 1.46), whereas the 47% higher risk of bleeding was statistically significant (OR 1.47, 95% CI 1.14 to 1.88). CONCLUSIONS: PDH prophylaxis after bariatric surgery is uncommon. In our analysis, use was not associated with a lower VTE risk but was associated with a higher bleeding risk.
引用
- Fennern EB, Farjah F, Chen JY, et al. Use of post-discharge heparin prophylaxis and the risk of venous thromboembolism and bleeding following bariatric surgery. Surg Endosc. 2020. PMID: 33025253. doi:10.1007/s00464-020-08049-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。